Autolus Therapeutics (AUTL) Payables (2017 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Payables of $3.1 million for Q4 2025, up 56.58% year-on-year from $2.0 million in Q4 2024, and down 71.89% on a QoQ basis from $11.0 million in Q3 2025.
Autolus Therapeutics (AUTL) Payables (2017 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Payables for 9 consecutive years, with $3.1 million the latest figure, recorded in Q4 2025.
- Quarterly Payables rose 56.58% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (up 56.58% YoY) and the FY2025 annual result came in at $3.1 million, up 56.58% from the prior year.
- Payables declined to $3.1 million in Q4 2025 per AUTL's latest filing, from $11.0 million in the prior quarter.
- Over the last five years, Payables for AUTL reached as high as $11.0 million in Q3 2025 and fell as low as $103000.0 in Q4 2023.
- A 5-year average of $2.1 million and a median of $1.3 million in 2021 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables tumbled 93.23% — and 2023, when it jumped 2293.83%.
- Year by year, Payables stood at $431000.0 in 2021, then climbed by 23.2% to $531000.0 in 2022, then slumped by 80.6% to $103000.0 in 2023, then soared by 1811.65% to $2.0 million in 2024, then soared by 56.58% to $3.1 million in 2025.
- According to Business Quant data, Payables over the past three periods registered $3.1 million, $11.0 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | 3.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 10.97 Mn |
| Jun 30, 2025 | 5.41 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 103,000.00 |
| Sep 30, 2023 | 661,000.00 |
| Jun 30, 2023 | 3.88 Mn |
| Mar 31, 2023 | 353,000.00 |
| Dec 31, 2022 | 531,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Dec 31, 2021 | 431,000.00 |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 1.12 Mn |
| Mar 31, 2021 | 2.26 Mn |